TRANSACTION CO.,Ltd. (7818.T)
JPY 2597.0
(0.27%)
JPY 2597.0
(0.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 5.8 Billion JPY | 17.64% |
| 2023 | 4.93 Billion JPY | 43.79% |
| 2022 | 3.42 Billion JPY | 14.38% |
| 2021 | 2.98 Billion JPY | 0.28% |
| 2020 | 2.69 Billion JPY | 35.86% |
| 2019 | 2.04 Billion JPY | 20.78% |
| 2018 | 1.81 Billion JPY | 22.38% |
| 2017 | 1.48 Billion JPY | 36.02% |
| 2016 | 1.09 Billion JPY | 86.62% |
| 2015 | 460.91 Million JPY | -15.83% |
| 2014 | 699.63 Million JPY | 4.15% |
| 2013 | 789.3 Million JPY | 22.34% |
| 2012 | 663.93 Million JPY | 39.74% |
| 2011 | 573.94 Million JPY | 12.2% |
| 2010 | 387.41 Million JPY | 33.89% |
| 2009 | 203.33 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 1.33 Billion JPY | 0.97% |
| 2024 Q4 | 1.51 Billion JPY | 12.34% |
| 2024 Q2 | 1.23 Billion JPY | -13.89% |
| 2024 Q1 | 1.51 Billion JPY | 51.54% |
| 2023 Q1 | 1.25 Billion JPY | 48.04% |
| 2023 Q4 | 986.78 Million JPY | -31.66% |
| 2023 FY | - JPY | 43.79% |
| 2023 Q2 | 1.1 Billion JPY | -12.25% |
| 2023 Q3 | 1.44 Billion JPY | 30.99% |
| 2022 Q2 | 835.7 Million JPY | 5.89% |
| 2022 Q4 | 848.48 Million JPY | 1.88% |
| 2022 Q3 | 832.86 Million JPY | -0.34% |
| 2022 Q1 | 789.25 Million JPY | 58.29% |
| 2022 FY | - JPY | 14.38% |
| 2021 Q3 | 742.41 Million JPY | 2.37% |
| 2021 Q4 | 498.61 Million JPY | -32.84% |
| 2021 FY | - JPY | 0.28% |
| 2021 Q1 | 913.17 Million JPY | 50.41% |
| 2021 Q2 | 725.25 Million JPY | -20.58% |
| 2020 Q2 | 473.13 Million JPY | -29.11% |
| 2020 Q3 | 1.11 Billion JPY | 135.02% |
| 2020 FY | - JPY | 35.86% |
| 2020 Q1 | 667.43 Million JPY | 60.36% |
| 2020 Q4 | 607.1 Million JPY | -45.4% |
| 2019 FY | - JPY | 20.78% |
| 2019 Q3 | 601.58 Million JPY | 34.58% |
| 2019 Q4 | 416.2 Million JPY | -30.82% |
| 2019 Q1 | 610.78 Million JPY | 60.81% |
| 2019 Q2 | 447.01 Million JPY | -26.81% |
| 2018 Q3 | 488.7 Million JPY | 343.8% |
| 2018 FY | - JPY | 22.38% |
| 2018 Q2 | -200.45 Million JPY | -119.16% |
| 2018 Q1 | 1.04 Billion JPY | 193.85% |
| 2018 Q4 | 379.82 Million JPY | -22.28% |
| 2017 Q4 | -1.11 Billion JPY | -211.14% |
| 2017 Q3 | 1 Billion JPY | 37.98% |
| 2017 Q1 | 790.14 Million JPY | 186.71% |
| 2017 Q2 | 727 Million JPY | -7.99% |
| 2017 FY | - JPY | 36.02% |
| 2016 Q2 | 621.64 Million JPY | -1.23% |
| 2016 FY | - JPY | 86.62% |
| 2016 Q1 | 629.39 Million JPY | 160.34% |
| 2016 Q3 | 695.92 Million JPY | 11.95% |
| 2016 Q4 | -911.2 Million JPY | -230.93% |
| 2015 Q4 | -1.04 Billion JPY | -301.5% |
| 2015 Q3 | 517.63 Million JPY | 6.64% |
| 2015 Q2 | 485.38 Million JPY | -15.12% |
| 2015 Q1 | 571.86 Million JPY | 157.79% |
| 2015 FY | - JPY | -15.83% |
| 2014 FY | - JPY | 4.15% |
| 2014 Q4 | -989.51 Million JPY | -265.72% |
| 2014 Q3 | 597.09 Million JPY | 22.08% |
| 2014 Q2 | 489.1 Million JPY | -9.51% |
| 2014 Q1 | 540.49 Million JPY | 158.31% |
| 2013 Q4 | -926.92 Million JPY | -266.87% |
| 2013 Q2 | 423.11 Million JPY | -24.48% |
| 2013 Q1 | 560.29 Million JPY | 163.35% |
| 2013 Q3 | 555.47 Million JPY | 31.28% |
| 2013 FY | - JPY | 22.34% |
| 2012 Q4 | -884.47 Million JPY | -271.29% |
| 2012 Q3 | 516.37 Million JPY | 30.73% |
| 2012 Q1 | 468.32 Million JPY | 157.92% |
| 2012 Q2 | 394.98 Million JPY | -15.66% |
| 2012 FY | - JPY | 39.74% |
| 2011 FY | - JPY | 12.2% |
| 2011 Q4 | -808.5 Million JPY | -267.38% |
| 2011 Q2 | 375.7 Million JPY | 8.55% |
| 2011 Q1 | 346.09 Million JPY | 133.53% |
| 2011 Q3 | 483.04 Million JPY | 28.57% |
| 2010 Q3 | 362.51 Million JPY | 0.0% |
| 2010 FY | - JPY | 33.89% |
| 2010 Q4 | -1.03 Billion JPY | -384.74% |
| 2009 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Kitanotatsujin Corporation | 1.58 Billion JPY | -265.844% |
| Euglena Co., Ltd. | 676 Million JPY | -759.357% |
| BEAUTY GARAGE Inc. | 1.96 Billion JPY | -195.662% |
| Axas Holdings Co.,Ltd. | 555.75 Million JPY | -945.285% |
| C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -44.761% |
| Kao Corporation | 154.49 Billion JPY | 96.24% |
| Niitaka Co., Ltd. | 1.36 Billion JPY | -324.181% |
| Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 88.109% |
| Shiseido Company, Limited | 106.46 Billion JPY | 94.543% |
| Lion Corporation | 42.31 Billion JPY | 86.271% |
| Mandom Corporation | 6.69 Billion JPY | 13.282% |
| Ivy Cosmetics Corporation | 242.6 Million JPY | -2294.582% |
| Milbon Co., Ltd. | 7.8 Billion JPY | 25.526% |
| Nippon Shikizai, Inc. | 1.28 Billion JPY | -350.828% |
| Fancl Corporation | 16.6 Billion JPY | 65.011% |
| KOSÉ Corporation | 26.85 Billion JPY | 78.37% |
| Cota Co., Ltd. | 2.26 Billion JPY | -156.087% |
| HABA Laboratories,Inc. | -1.31 Billion JPY | 542.0% |
| C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -3280.481% |
| Pola Orbis Holdings Inc. | 23.17 Billion JPY | 74.935% |
| Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 52.554% |
| Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -4584.884% |
| Almado, Inc. | 983.21 Million JPY | -490.841% |
| I-ne CO., LTD. | 4.7 Billion JPY | -23.601% |
| Premier Anti-Aging Co., Ltd. | -627 Million JPY | 1026.516% |
| Liberta Co.,Ltd. | 318.19 Million JPY | -1725.708% |
| AXXZIA Inc. | 1.28 Billion JPY | -351.552% |
| S.T. Corporation | 2.62 Billion JPY | -121.221% |
| Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 81.665% |
| Earth Corporation | 10.6 Billion JPY | 45.237% |
| Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -430.746% |
| Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 1112.099% |
| Ya-Man Ltd. | 1.43 Billion JPY | -304.327% |
| MTG Co., Ltd. | 4.39 Billion JPY | -32.209% |
| SHOBIDO Corporation | 1.11 Billion JPY | -423.264% |
| Artnature Inc. | 3.78 Billion JPY | -53.4% |
| Pigeon Corporation | 15.8 Billion JPY | 63.247% |
| Unicharm Corporation | 178.01 Billion JPY | 96.737% |
| Paltac Corporation | 35.92 Billion JPY | 83.829% |
| CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -76.842% |